Pharmaceuticals Current Events | Pharmaceuticals News | 3
|
|
|
Sort By:
Page Views | Date |
Sweet -- sugared polymer a new weapon against allergies and asthma
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. view more (2009-11-20)
MSU study finds media coverage of breast cancer focuses too little on prevention
News coverage of breast cancer focuses too much on treatments and not enough on prevention, a trend that could prove risky in the long run for many women, say researchers at Michigan State University. view more (2008-04-16)
Stanford scientist to discuss new approach to treating hepatitis C virus
Last year Peter Sarnow, PhD, professor of microbiology and immunology at the Stanford University School of Medicine, identified a previously unknown mechanism that the hepatitis C virus uses to replicate, yielding a promising new approach to combating the disease-causing virus. view more (2006-04-06)
First-time analysis reveals millions of Europeans left at risk from influenza
A powerful analysis from this month's Vaccine 1 highlights the huge gap between current vaccination coverage across Europe and the recommendations endorsed by the European Union. view more (2006-11-20)
Sir Isaac Newton Visits California
Famous physicist Isaac Newton and astronomer Galileo are visiting Falkirk schools, including California Primary School, to celebrate National Science Week. Actor Peter Joyce will bring the two historical figures to life in performances to over 1700 children as part of the Society of Chemical Industry (SCI) Scotland Section annual events programme. view more (2002-03-11)
Molecular drug pump may help reduce risk of Alzheimer's
A molecule that has long been an obstacle to cancer chemotherapy and drug treatments for brain disorders may soon become an ally in the fight against Alzheimer's disease, according to researchers at Washington University School of Medicine in St. Louis and the University of Rochester. view more (2005-10-21)
DISTINGUISHED SERVICE AWARD BESTOWED - University head applauded for dedicated service to international Society
Dr Richard Greenwood, Head of the School of Biological Sciences at the University of Portsmouth, was awarded with the prestigious Society of Chemical Industry (SCI) Distinguished Service Award yesterday at SCI International Headquarters in Belgrave Square, London, UK. The award was given in recognition of Dr Greenwood's extensive service to the... view more... (2003-04-25)
Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
The Cystic Fibrosis Foundation announced today that VX-770, an oral drug in development that targets a basic defect in CF, showed promising results in an ongoing Phase 2a clinical trial for patients who carry the G551D mutation of CF. The drug is being developed by Vertex Pharmaceuticals Incorporated. view more (2008-03-28)
Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. view more (2009-11-23)
Chemistry & Industry Magazine - cover date 21 July 2003
NEWS Fruit lasts 12 times longer with new natural packaging A sugary coating that can extend the shelf life of peeled fruit and vegetables by as much as 12 weeks has been developed. The coating is a mixture of sugary, acidic and antioxidant compounds dissolved in water. The extension of shelf life depends on several factors, including the presence... view more... (2003-07-17)
Unilever Chairman Receives Science Society Accolade
Unilever Chairman, Niall FitzGerald, will be awarded with the SCI (Society of Chemical Industry) Centenary Medal on the 15th January. Guests from the industry will hear his speech Science in Action 150 Million Times a Day at dinner being held at the National Liberal Club in London. The award is given to acknowledge influential and prominent... view more... (2004-01-13)
Dr Lars Abrahmsén appointed Chief Scientific Officer of Affibody
Affibody today announced the strengthening of the management team by the appointment of Dr Lars Abrahmsén as Chief Scientific Officer. Lars Abrahmsén succeeds Stefan St'åhl, one of Affibody's founders. Professor St'åhl wished to return to academia, and has returned to his academic professorship, but remains as scientific... view more... (2004-01-27)
Lisdexamfetamine dimesylate in ADHD phase 3 data presented
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that their investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX), yielded a 60 percent improvement in the primary rating scale scores for symptoms of... view more... (2006-10-30)
New drug reverses effects of sleep deprivation on brain
Research in monkeys suggests that a new drug can temporarily improve performance and reverse the effects of sleep deprivation on the brain. view more (2005-08-23)
Study urges compensation-based approach to drug patent compulsory licensing
A Penn State researcher argues that ambiguous international rules outlining when and how governments may "break" pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines. view more (2007-07-11)
Dormant Bugs Dodge Antibiotics
A new way to attack harmful bacteria by affecting normal growth has been discovered by scientists from Aberystwyth. The research is presented today, Wednesday 10 September 2003, by Dr Adriana Ravagnani at the Society for General Microbiology's meeting at UMIST in Manchester. Under hostile conditions some bacteria have the ability to go into and... view more... (2003-08-27)
THE ROYAL INSTITUTION AT FUTUROSCOPE
view more (1998-09-15)
TGen seeks emergency FDA approval of new swine flu test
The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus. view more (2009-10-30)
The Ethics of Patenting DNA and Proteins
Many companies and universities throughout the world are seeking to file patents on gene sequences and proteins. Questions remain, however, over the moral implications of protecting rights to property in this kind of way. The Nuffield Council on Bioethics is holding a series of Roundtable meetings to consider the ethical and legal issues raised by... view more... (2000-09-06)
Study shows new imaging tracer clarifies cause of chest pain up to 30 hours after pain stops
A national team of researchers, led by a cardiovascular nuclear medicine specialist at the University of Maryland Medical Center, has demonstrated for the first time that an experimental radioactive compound can show images of heart damage up to 30 hours after a brief interruption of blood flow and oxygen. view more (2005-09-27)
|
|
|
|
Sort By:
Page Views | Date |
|
